HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

José W A van der Hoorn Selected Research

AT04A vaccine

8/2017The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


José W A van der Hoorn Research Topics

Disease

12Atherosclerosis
08/2017 - 02/2004
5Inflammation (Inflammations)
08/2017 - 01/2012
2Coronary Disease (Coronary Heart Disease)
08/2017 - 11/2014
2Body Weight (Weight, Body)
11/2015 - 04/2012
2Dyslipidemias (Dyslipidemia)
11/2015 - 05/2009
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022
1Alcoholic Fatty Liver
11/2015
1Insulin Resistance
11/2015
1Weight Gain
11/2015
1Fibrosis (Cirrhosis)
11/2015
1Type 2 Diabetes Mellitus (MODY)
11/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2015
1Myocardial Infarction
09/2015
1Cardiovascular Diseases (Cardiovascular Disease)
09/2015
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
08/2014
1Demyelinating Diseases (Demyelinating Disease)
08/2014
1Disease Progression
08/2014
1Hyperlipoproteinemia Type III (Broad Beta Disease)
01/2013
1Hypertension (High Blood Pressure)
01/2012
1Thyroid Neoplasms (Thyroid Cancer)
05/2009
1Hypertriglyceridemia
05/2009
1Coronary Artery Disease (Coronary Atherosclerosis)
02/2004

Drug/Important Bio-Agent (IBA)

9Apolipoproteins E (ApoE)IBA
08/2017 - 12/2007
6LipidsIBA
08/2017 - 02/2004
6Atorvastatin (Lipitor)FDA Link
01/2015 - 02/2004
5CholesterolIBA
08/2017 - 05/2009
5HDL CholesterolIBA
11/2015 - 05/2008
4Cholesterol Ester Transfer ProteinsIBA
11/2015 - 05/2008
4oxidized low density lipoproteinIBA
11/2015 - 05/2009
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2014 - 02/2004
3LDL CholesterolIBA
08/2017 - 11/2014
2anacetrapibIBA
11/2015 - 01/2015
2Niacin (Nicotinic Acid)FDA LinkGeneric
01/2013 - 09/2012
1AT04A vaccineIBA
08/2017
1Proprotein Convertase 9IBA
08/2017
1LDL Receptors (LDL Receptor)IBA
08/2017
1VaccinesIBA
08/2017
1salicylsalicylic acid (salsalate)IBA
11/2015
1alirocumabIBA
10/2014
1Myelin-Oligodendrocyte GlycoproteinIBA
08/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
08/2014
1ResveratrolIBA
08/2013
1Simvastatin (Zocor)FDA LinkGeneric
01/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2012
1aliskirenFDA Link
01/2012
1Renin InhibitorsIBA
01/2012
1ApolipoproteinsIBA
05/2009
1Triglycerides (Triacylglycerol)IBA
05/2009
1HDL LipoproteinsIBA
05/2009
1Retinoid X Receptors (Retinoid X Receptor)IBA
05/2009
1Apolipoprotein E3IBA
05/2009
1VLDL LipoproteinsIBA
05/2009
1Bexarotene (LGD1069)FDA Link
05/2009
1torcetrapibIBA
05/2008
1Angiotensin Receptor AntagonistsIBA
12/2007
1Pravastatin (Pravachol)FDA LinkGeneric
12/2007
1olmesartanIBA
12/2007
1Biomarkers (Surrogate Marker)IBA
02/2004
1Amlodipine (Norvasc)FDA LinkGeneric
02/2004

Therapy/Procedure

4Therapeutics
08/2013 - 02/2004
1One-Lung Ventilation
01/2022